Seqirus to build $800m flu vaccine facility in Melbourne

Influenza vaccine provider Seqirus has announced plans to construct a world-class biotech manufacturing facility in Australia to supply influenza vaccines to Australia and the rest of the world. The facility will produce influenza vaccines using cell-based technology for use in influenza pandemics and seasonal vaccination programs and, once complete, will reportedly be the only cell-based […]